|
|
|||||||||||
Department of Psychological Medicine, Wales College of Medicine, Cardiff University, Wales, UK
Biostatistics and Bioinformatics Unit, Wales College of Medicine, Cardiff University, Wales, UK
Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Birmingham, Wales, UK
Department of Psychiatry, University of Newcastle, Wales, UK
Department of Psychological Medicine, Wales College of Medicine, Cardiff University, Wales, UK
Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Birmingham, Wales, UK
Department of Psychological Medicine, Wales College of Medicine, Cardiff University, Cardiff, Wales, UK
Correspondence: Professor Nick Craddock, Department of Psychological Medicine, Henry Wellcome Building, Wales College of Medicine, Cardiff University, Heath Park, Cardiff CF4 4XN, UK. Tel: +44 (0)2920 744663; fax: +44 (0) 22920 746554; e-mail: craddockn{at}cardiff.ac.uk
Declaration of interest N.C. and M.J.O. are consultants to GlaxoSmithKline and have received grant funding and honoraria from GlaxoSmithKline, AstraZeneca and Eli Lilly. M.C. O'D., A.H.Y., L.J. and G.K. have received honoraria from GlaxoSmithKline, AstraZeneca and Eli Lilly. G.K. has received grant funding from Janssen. Funding detailed in Acknowledgements.
Background Brain-derived neurotrophic factor (BDNF) influences neuronal survival, proliferation and plasticity. Three family-based studies have shown association of the common Valine (Val) allele of the Val66Met polymorphism of the BDNF gene with susceptibility to bipolar disorder.
Aims To replicate this finding.
Method We genotyped the Val66Met polymorphism in our UK White bipolar case-control sample (n=3062).
Results We found no overall evidence of allele or genotype association. However, we found association with disease status in the subset of 131 individuals that had experienced rapid cycling at some time (P=0.004). We found a similar association on re-analysis of our previously reported family-based association sample (P < 0.03, one-tailed test).
Conclusions Variation at the Val66Met polymorphism of BDNF does not play a major role in influencing susceptibility to bipolar disorder as a whole, but is associated with susceptibility to the rapid-cycling subset of the disorder.
Related articles in BJP:
This article has been cited by other articles:
![]() |
Bibliography BIPOLAR DISORDER Focus, January 1, 2007; 5(1): 40 - 43. [Full Text] [PDF] |
||||
![]() |
Abstracts FOR BIPOLAR DISORDER Focus, January 1, 2007; 5(1): 44 - 58. [Full Text] [PDF] |
||||
![]() |
D. del Toro, J. M. Canals, S. Gines, M. Kojima, G. Egea, and J. Alberch Mutant huntingtin Impairs the Post-Golgi Trafficking of Brain-Derived Neurotrophic Factor But Not Its Val66Met Polymorphism J. Neurosci., December 6, 2006; 26(49): 12748 - 12757. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. MULLER, V. DE LUCA, T. SICARD, N. KING, J. STRAUSS, and J. L. KENNEDY Brain-derived neurotrophic factor (BDNF) gene and rapid-cycling bipolar disorder: Family-based association study The British Journal of Psychiatry, October 1, 2006; 189(4): 317 - 323. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |